€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating
LABIOTECH.eu – April 2020, 22nd
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against solid tumors into clinical trials within a year.
Led by the US-Japanese venture capital firm Remiges Ventures, the Series A round also included contributions from Japanese investment firm ANRI and French private equity investor Irdi Soridec Gestion (…)